BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31517024)

  • 1. Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology.
    Barupal DK; Baillie R; Fan S; Saykin AJ; Meikle PJ; Arnold M; Nho K; Fiehn O; Kaddurah-Daouk R;
    Alzheimers Dement (Amst); 2019 Dec; 11():619-627. PubMed ID: 31517024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
    Kling MA; Goodenowe DB; Senanayake V; MahmoudianDehkordi S; Arnold M; Massaro TJ; Baillie R; Han X; Leung YY; Saykin AJ; Nho K; Kueider-Paisley A; Tenenbaum JD; Wang LS; Shaw LM; Trojanowski JQ; Kaddurah-Daouk RF;
    Alzheimers Dement; 2020 Sep; 16(9):1234-1247. PubMed ID: 32715599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic Effects of the Lipid Metabolic Pathway Accelerated Pathological Changes and Disrupted Default Mode Network Trajectory Across the Alzheimer's Disease Spectrum.
    Zang F; Zhu Y; Liu X; Fan D; Wang Q; Zhang Q; He C; Zhang Z; Xie C; ;
    J Clin Psychiatry; 2021 Sep; 82(6):. PubMed ID: 34551222
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer's Disease Cohort.
    Fonteh AN; Cipolla M; Chiang AJ; Edminster SP; Arakaki X; Harrington MG
    Front Physiol; 2020; 11():83. PubMed ID: 32116789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case-control study within the ATBC cohort.
    Barupal DK; Ramos ML; Florio AA; Wheeler WA; Weinstein SJ; Albanes D; Fiehn O; Graubard BI; Petrick JL; McGlynn KA
    Int J Cancer; 2024 Feb; 154(3):454-464. PubMed ID: 37694774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression.
    Jahn T; Clark C; Kerksiek A; Lewczuk P; Lütjohann D; Popp J
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105785. PubMed ID: 33171206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Proitsi P; Kim M; Whiley L; Simmons A; Sattlecker M; Velayudhan L; Lupton MK; Soininen H; Kloszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Powell JF; Dobson RJ; Legido-Quigley C
    Alzheimers Dement; 2017 Feb; 13(2):140-151. PubMed ID: 27693183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    Teitsdottir UD; Halldorsson S; Rolfsson O; Lund SH; Jonsdottir MK; Snaedal J; Petersen PH
    J Alzheimers Dis; 2021; 81(1):231-244. PubMed ID: 33814423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection.
    Huang H; Ye G; Lai SQ; Zou HX; Yuan B; Wu QC; Wan L; Wang Q; Zhou XL; Wang WJ; Cao YP; Huang JF; Chen SL; Yang BC; Liu JC
    Front Cardiovasc Med; 2021; 8():757022. PubMed ID: 34778409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an A
    Yi M; Zhang C; Zhang Z; Yi P; Xu P; Huang J; Peng W
    Oxid Med Cell Longev; 2020; 2020():5243453. PubMed ID: 32655770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampus Proteomics and Brain Lipidomics Reveal Network Dysfunction and Lipid Molecular Abnormalities in APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang X; Liu W; Cao Y; Tan W
    J Proteome Res; 2020 Aug; 19(8):3427-3437. PubMed ID: 32510958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
    J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
    J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Cerebrospinal Fluid Levels of Hemopexin Are Associated With Increased Alzheimer's Pathology, Hippocampal Hypometabolism, and Cognitive Decline.
    Ashraf AA; Dani M; So PW
    Front Mol Biosci; 2020; 7():590979. PubMed ID: 33392254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.